Davita Healthcare Partners (DVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 3,121,332 | 3,000,369 | 2,872,699 | 2,916,887 | 2,948,694 |
| Cost of Goods | 2,067,315 | 2,055,844 | 2,058,189 | 2,088,681 | 2,085,555 |
| Gross Profit | 1,054,017 | 944,525 | 814,510 | 828,207 | 863,139 |
| Operating Expenses | 558,393 | 540,078 | 503,054 | 572,635 | 551,907 |
| Operating Income | 495,939 | 405,291 | 311,645 | 256,252 | 311,787 |
| Other Income | -117,730 | -110,096 | -97,022 | -108,759 | -104,578 |
| Pre-tax Income | 378,209 | 295,195 | 214,623 | 147,493 | 207,209 |
| Income Tax | 68,848 | 48,818 | 43,955 | 34,330 | 42,515 |
| Net Income Continuous | 309,361 | 246,377 | 170,668 | 113,163 | 164,694 |
| Minority Interests | 62,729 | 67,686 | 55,121 | 58,512 | 59,328 |
| Net Income | $246,632 | $178,691 | $115,547 | $68,103 | $105,366 |
| EPS Basic Total Ops | 2.70 | 1.96 | 1.28 | 0.81 | 1.16 |
| EPS Basic Continuous Ops | 3.39 | 2.71 | 1.89 | -1.08 | 1.81 |
| EPS Diluted Total Ops | 2.62 | 1.91 | 1.25 | 0.81 | 1.13 |
| EPS Diluted Continuous Ops | 3.29 | 2.64 | 1.85 | -1.01 | 1.77 |
| EBITDA(a) | $684,362 | $588,963 | $489,716 | $450,320 | $506,201 |